Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.3938
+0.0238 (6.43%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Applied Therapeutics Stock Forecast
APLT's stock price has decreased by -91.17% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Applied Therapeutics stock have an average target of 6.10, with a low estimate of 1.50 and a high estimate of 14. The average target predicts an increase of 1,449.01% from the current stock price of 0.39.
Analyst Consensus: Buy
* Price targets were last updated on Dec 20, 2024.
Analyst Ratings
The average analyst rating for Applied Therapeutics stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 23, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $4 → $1.5 | Hold | Maintains | $4 → $1.5 | +280.90% | Dec 20, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $13 → $2 | Strong Buy → Hold | Downgrades | $13 → $2 | +407.87% | Dec 2, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $13 → $8 | Strong Buy | Maintains | $13 → $8 | +1,931.49% | Nov 29, 2024 |
| Baird | Baird | Buy Maintains $14 → $5 | Buy | Maintains | $14 → $5 | +1,169.68% | Nov 29, 2024 |
Financial Forecast
Revenue This Year
8.50M
from 455.00K
Increased by 1,768.13%
Revenue Next Year
39.21M
from 8.50M
Increased by 361.28%
EPS This Year
-0.77
from -0.76
EPS Next Year
-0.63
from -0.77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.5M | 57.0M | 64.1M | ||
| Avg | 8.5M | 39.2M | 62.3M | ||
| Low | 4.9M | 20.0M | 59.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2,207.7% | 570.8% | 63.5% | ||
| Avg | 1,768.1% | 361.3% | 58.8% | ||
| Low | 976.9% | 134.7% | 52.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.60 | -0.36 | -0.34 | ||
| Avg | -0.77 | -0.63 | -0.33 | ||
| Low | -0.88 | -0.93 | -0.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.